172 related articles for article (PubMed ID: 32520028)
1. Cationic carboxylate and thioacetate ruthenium(ii) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cells.
Lovison D; Allegri L; Baldan F; Ballico M; Damante G; Jandl C; Baratta W
Dalton Trans; 2020 Jun; 49(24):8375-8388. PubMed ID: 32520028
[TBL] [Abstract][Full Text] [Related]
2. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
[TBL] [Abstract][Full Text] [Related]
3. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
[TBL] [Abstract][Full Text] [Related]
4. Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells.
Lovison D; Alessi D; Allegri L; Baldan F; Ballico M; Damante G; Galasso M; Guardavaccaro D; Ruggieri S; Melchior A; Veclani D; Nardon C; Baratta W
Chemistry; 2022 Jun; 28(33):e202200200. PubMed ID: 35394095
[TBL] [Abstract][Full Text] [Related]
5. Pro-apoptotic activity of ruthenium 1-methylimidazole complex on non-small cell lung cancer.
Dias JSM; Silva HVR; Ferreira-Silva GÁ; Ionta M; Corrêa CC; Almeida F; Colina-Vegas L; Barbosa MIF; Doriguetto AC
J Inorg Biochem; 2018 Oct; 187():1-13. PubMed ID: 30015231
[TBL] [Abstract][Full Text] [Related]
6. Cyclometalated and NNN Terpyridine Ruthenium Photocatalysts and Their Cytotoxic Activity.
Ballico M; Alessi D; Aneggi E; Busato M; Zuccaccia D; Allegri L; Damante G; Jandl C; Baratta W
Molecules; 2024 May; 29(9):. PubMed ID: 38731639
[TBL] [Abstract][Full Text] [Related]
7. Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
Martínez-Peña F; Infante-Tadeo S; Habtemariam A; Pizarro AM
Inorg Chem; 2018 May; 57(9):5657-5668. PubMed ID: 29688005
[TBL] [Abstract][Full Text] [Related]
8. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
9. Study of the cytotoxic and genotoxic potential of the carbonyl ruthenium(II) compound, ct-[RuCl(CO)(dppb)(bipy)]PF
Carnizello AP; Alves JM; Pereira DE; Campos JCL; Barbosa MIF; Batista AA; Tavares DC
J Appl Toxicol; 2019 Apr; 39(4):630-638. PubMed ID: 30460706
[TBL] [Abstract][Full Text] [Related]
10. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
11. Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.
Ludwig G; Mojić M; Bulatović M; Mijatović S; Maksimović-Ivanić D; Steinborn D; Kaluđerović GN
Anticancer Agents Med Chem; 2016; 16(11):1455-1460. PubMed ID: 26510901
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].
Carnizello AP; Barbosa MI; Martins M; Ferreira NH; Oliveira PF; Magalhães GM; Batista AA; Tavares DC
J Inorg Biochem; 2016 Nov; 164():42-48. PubMed ID: 27613330
[TBL] [Abstract][Full Text] [Related]
13. Ru
Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
[TBL] [Abstract][Full Text] [Related]
15. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction.
Ribeiro GH; Guedes APM; de Oliveira TD; de Correia CRSTB; Colina-Vegas L; Lima MA; Nóbrega JA; Cominetti MR; Rocha FV; Ferreira AG; Castellano EE; Teixeira FR; Batista AA
Inorg Chem; 2020 Oct; 59(20):15004-15018. PubMed ID: 32997499
[TBL] [Abstract][Full Text] [Related]
16. New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent.
Guerriero A; Oberhauser W; Riedel T; Peruzzini M; Dyson PJ; Gonsalvi L
Inorg Chem; 2017 May; 56(10):5514-5518. PubMed ID: 28443659
[TBL] [Abstract][Full Text] [Related]
17. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors.
de Camargo MS; De Grandis RA; da Silva MM; da Silva PB; Santoni MM; Eismann CE; Menegário AA; Cominetti MR; Zanelli CF; Pavan FR; Batista AA
Biometals; 2019 Feb; 32(1):89-100. PubMed ID: 30506342
[TBL] [Abstract][Full Text] [Related]
18. Tuning Polyamidoamine Design To Increase Uptake and Efficacy of Ruthenium Complexes for Photodynamic Therapy.
Mascheroni L; Dozzi MV; Ranucci E; Ferruti P; Francia V; Salvati A; Maggioni D
Inorg Chem; 2019 Nov; 58(21):14586-14599. PubMed ID: 31618015
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and in vitro cytotoxicity of ruthenium(II) metronidazole complexes: Cell cycle arrest at G1/S transition and apoptosis induction in MCF-7 cells.
Candido CC; Silva HVR; Zavan B; Ionta M; Barbosa MIF; Doriguetto AC
J Inorg Biochem; 2022 Dec; 237():112022. PubMed ID: 36244314
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.
Golbaghi G; Pitard I; Lucas M; Haghdoost MM; de Los Santos YL; Doucet N; Patten SA; Sanderson JT; Castonguay A
Eur J Med Chem; 2020 Feb; 188():112030. PubMed ID: 31945643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
